Mystery Surrounds Pliant IPF Trial Pause As Stock Sinks

 
• By Kevin Grogan

The US company has voluntarily halted enrolment in BEACON-IPF of bexotegrast on the recommendation of the trial’s independent data safety monitoring board, leaving analysts puzzled over the drug's prospects for the lung disease.

pill pause
• Source: Nieslen Hobbs; the Pink Sheet | Shutterstock images

More from Clinical Trials

More from Therapy Areas